NAS:KZR (USA) Also Trade In: Germany
Kezar Life Sciences Inc $ 4.74 -0.11 (-2.17%)
Warning! GuruFocus has detected 2 Severe warning signs with KZR. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for KZR (Kezar Life Sciences Inc) from 2018 to Oct 01 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Kezar Life Sciences stock (KZR) PE ratio as of Oct 01 2020 is 0. More Details
Kezar Life Sciences PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Kezar Life Sciences PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:VXRT NAS:LXRX NAS:SBBP NAS:ARAV NAS:LYRA NAS:XERS NAS:ISEE NAS:KALV NAS:IFRX NAS:NRBO OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 4000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and protein secretion program.